Cyllene Therapeutics
Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases
€33MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases
Develops prescription therapeutics and skincare products for cellular longevity and skin health